Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
KG Roberts, SC Reshmi, RC Harvey… - Blood, The Journal …, 2018 - ashpublications.org
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL; BCR-ABL1–like
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …
Ph-like acute lymphoblastic leukemia
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a newly
identified high-risk (HR) B-lineage ALL subtype, accounting for∼ 15% of children with …
identified high-risk (HR) B-lineage ALL subtype, accounting for∼ 15% of children with …
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group
SC Reshmi, RC Harvey, KG Roberts… - Blood, The Journal …, 2017 - ashpublications.org
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …
subtype characterized by genomic alterations that activate cytokine receptor and kinase …
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner… - New England journal …, 2014 - Mass Medical Soc
Background Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL …
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL …
High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults
KG Roberts, Z Gu, D Payne-Turner… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Philadelphia chromosome (Ph)–like acute lymphoblastic leukemia (ALL) is a high-
risk subtype of childhood ALL characterized by kinase-activating alterations that are …
risk subtype of childhood ALL characterized by kinase-activating alterations that are …
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
N Jain, KG Roberts, E Jabbour, K Patel… - Blood, The Journal …, 2017 - ashpublications.org
Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL) is a high-risk
subtype of ALL in children. There are conflicting data on the incidence and prognosis of Ph …
subtype of ALL in children. There are conflicting data on the incidence and prognosis of Ph …
High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL
Treatment of patients with Philadelphia chromosome-positive B-cell acute lymphoblastic
leukemia (Ph+ B-ALL) with tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib …
leukemia (Ph+ B-ALL) with tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib …
The biology of Philadelphia chromosome-like ALL
KG Roberts - Best Practice & Research Clinical Haematology, 2017 - Elsevier
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a recently
described subtype of B-cell precursor ALL with a gene expression profile similar to Ph …
described subtype of B-cell precursor ALL with a gene expression profile similar to Ph …
Philadelphia chromosome–like acute lymphoblastic leukemia
CH Pui, KG Roberts, JJ Yang, CG Mullighan - Clinical Lymphoma Myeloma …, 2017 - Elsevier
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a recently
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
described B-cell precursor ALL with a gene expression profile and a high frequency of IKZF1 …
[HTML][HTML] High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment
SL Heatley, T Sadras, CH Kok, E Nievergall… - …, 2017 - ncbi.nlm.nih.gov
Acute lymphoblastic leukemia (ALL) remains a leading cause of cancer-related death in
children and young adults. Since the 1960s, improvements in the treatment of children with …
children and young adults. Since the 1960s, improvements in the treatment of children with …